With reference to the report published, the global healthcare IT market was prized by USD 74.2 billion in 2020
These key players are implementing different strategic initiatives to improve their shares in the market for over the counter drugs. Johnson and Johnson is one of the largest healthcare companies that operates at a global level. The company offers OTC products under its consumer health segment. As...
The global skincare market size was valued at USD 115.65 billion in 2024. The market is projected to grow from USD 122.11 billion in 2025 to USD 194.05 billion by 2032, exhibiting a CAGR of 6.84% during the forecast period. Asia Pacific dominated the skin care market with a market share ...
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and...
Technological breakthroughs, particularly in devices, are changing the course of heart failure (HF) management. The focus on developing technologically advanced products is significantly increasing with the introduction of accessible and novel technologies that are driving a growth factor for healthcare educ...
Daniel started his career at a major pharmaceutical company and later in the NHS (National Health Service). Within pharma, Daniel managed the integration of the Welcome acquisition into Europe; implemented the UK pharmacy-agency distribution model, an industry first; managed a healthcare venture fund...
Nicola Scott Consulting is a Specialist Healthcare Market Research and B2B Customer Insights Consultancy based in Sydney, Australia.
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and...
The Congestive Heart Failure Treatment Devices Market size is estimated at USD 23.27 billion in 2025, and is expected to reach USD 31.94 billion by 2030, at a CAGR of 6.54% during the forecast period (2025-2030). Due to the high infection rate and lockdown regulations brought on by the ...
Following the failure of the Clinton national health insurance proposal in 1993, managed care experienced tremendous growth as employers sought to provide their employees with comprehensive coverage at reasonable costs. Managed care systems have been able to cut costs in health care in ways that govern...